ALGN moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 34 of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on ALGN as a result. In 58 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for ALGN just turned positive on October 08, 2026. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in 32 of 42 cases over the following month. The odds of a continued upward trend are 76%.
Following a +3.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in 192 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
ALGN broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ALGN entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. ALGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.610) is normal, around the industry mean (4.961). P/E Ratio (26.951) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.611) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.612) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
QCLR moved above its 50-day moving average on September 21, 2026 date and that indicates a change from a downward trend to an upward trend. In 24 of 29 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on QCLR as a result. In 54 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The 10-day moving average for QCLR crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 82%.
Following a +0.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where QCLR advanced for three days, in 208 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 275 of 359 cases where QCLR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
The 10-day RSI Indicator for QCLR moved out of overbought territory on October 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In 26 of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 65 cases where QCLR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for QCLR turned negative on October 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 30 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QCLR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
QCLR broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
ALGN | ||
|---|---|---|
OUTLOOK RATING 1..100 | 30 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 69 | |
PRICE GROWTH RATING 1..100 | 58 | |
P/E GROWTH RATING 1..100 | 22 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ALGN | QCLR | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 57% |
| Stochastic ODDS (%) | 1 day ago 73% | 1 day ago 62% |
| Momentum ODDS (%) | 1 day ago 73% | 1 day ago 68% |
| MACD ODDS (%) | 1 day ago 76% | 1 day ago 64% |
| TrendWeek ODDS (%) | 1 day ago 73% | 1 day ago 74% |
| TrendMonth ODDS (%) | 1 day ago 72% | 1 day ago 76% |
| Advances ODDS (%) | 1 day ago 70% | 17 days ago 78% |
| Declines ODDS (%) | 18 days ago 75% | 15 days ago 57% |
| BollingerBands ODDS (%) | 1 day ago 74% | 2 days ago 66% |
| Aroon ODDS (%) | 1 day ago 73% | 1 day ago 77% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALGN’s FA Score shows that 1 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALGN’s TA Score shows that 4 TA indicator(s) are bullish.
ALGN (@Pharmaceuticals: Other) experienced а +4.13% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.
ALGN is expected to report earnings on Oct 28, 2026.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
A.I.dvisor indicates that over the last year, ALGN has been closely correlated with NVST. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALGN jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To ALGN | 1D Price Change % | ||
|---|---|---|---|---|
| ALGN | 100% | +2.74% | ||
| NVST - ALGN | 71% Closely correlated | +3.36% | ||
| XRAY - ALGN | 58% Loosely correlated | +4.63% | ||
| LUNG - ALGN | 52% Loosely correlated | +2.73% | ||
| ICUI - ALGN | 50% Loosely correlated | +4.66% | ||
| ILMN - ALGN | 48% Loosely correlated | -4.76% | ||
More | ||||
A.I.dvisor indicates that over the last year, QCLR has been loosely correlated with SWKS. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if QCLR jumps, then SWKS could also see price increases.
| Ticker / NAME | Correlation To QCLR | 1D Price Change % | ||
|---|---|---|---|---|
| QCLR | 100% | N/A | ||
| SWKS - QCLR | 59% Loosely correlated | +0.21% | ||
| ZM - QCLR | 51% Loosely correlated | -3.26% | ||
| DOCU - QCLR | 40% Loosely correlated | +3.60% | ||
| OKTA - QCLR | 39% Loosely correlated | -3.50% | ||
| ALGN - QCLR | 36% Loosely correlated | +2.74% | ||
More | ||||